Stock listing
Lexeo Therapeutics, Inc.
Selected listing: LXEO · NASDAQ · USD · US
Lexeo Therapeutics, Inc. (NASDAQ:LXEO), Health Technology. Latest release Oct 1, 2026: Lexeo Therapeutics Announces Oral Presentation of LX2006…
- Ticker
- NASDAQ:LXEO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (Ticker: LXEO) is a public company based in the United States, focusing on innovative therapeutics. The company is committed to developing solutions that address significant medical needs.
Latest news from Lexeo Therapeutics, Inc.
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
September 30, 2026
Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia
September 23, 2026
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
September 23, 2026
Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia
September 22, 2026
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
September 2, 2026
Research Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. company profile
View the public company page for Lexeo Therapeutics, Inc. on 6ix.
Lexeo Therapeutics, Inc. news
Read company news and market updates connected to Lexeo Therapeutics, Inc..
Lexeo Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Lexeo Therapeutics, Inc..